Vanguard Capital Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
Vanguard Capital Management's MXCT Position: Q3 2026 in Review
Vanguard Capital Management reduced its MaxCyte (MXCT) stake by 0.55% in Q3 2026, selling an estimated $27.4K and leaving 4,008,963 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3119.
Vanguard Capital Management first reported a position in MXCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.96M in Q2 2026. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- Vanguard Capital Management held 4,008,963 shares of MaxCyte worth $4.49M as of Q3 2026.
- Vanguard Capital Management sold 22,321 MaxCyte shares in Q3 2026, an estimated $27.4K.
- MaxCyte made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3119 holding.
- Vanguard Capital Management first reported a position in MaxCyte in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's MaxCyte position peaked at $4.96M in Q2 2026.
- 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.